- Open Access
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
Journal of Ovarian Research volume 13, Article number: 28 (2020)
- The original article was published in Journal of Ovarian Research 2019 12:125
Correction to: J Ovarian Res (2019) 12:125
The original article  contains errors in Fig. 3c, Results and Discussion. The picture of cell cycle analysis of A2780 si-KAL in the original publication was incorrectly a repeat of A2780 si-NC, and the correct picture of A2780 si-KAL is updated.
Additionally, the data of G2/M phase and S phase are switched in Fig. 3c. Correspondingly, “G2 phase” in Results and Discussion of the original article (page 5, left column, line 16 and page 6, right column, line 22) should be changed to “S phase”, which still indicated that kallistatin inhibited the proliferation of ovarian cancer cells. The corrected Fig. 3 appears below.
The authors sincerely apologize for the errors. The errors do not affect the conclusion of the article.
Wu H, Li R, Zhang Z, et al. Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer. J Ovarian Res. 2019;12:125. https://doi.org/10.1186/s13048-019-0601-6.
About this article
Cite this article
Wu, H., Li, R., Zhang, Z. et al. Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer. J Ovarian Res 13, 28 (2020). https://doi.org/10.1186/s13048-020-00628-5